Regulus Therapeutics(RGLS)- NASDAQ
Company Description
Regulus Therapeutics, Inc. engages in the discovery and development of drugs target microRNAs to treat a broad range of diseases. It is developing RG-101, which targets miR-122, a host factor for the hepatitis C virus infection. The company was founded in September 2007 and is headquartered in... More
Sector: Healthcare
Industry: Drug Related Products
Country: United States